跳到主要內容

臺灣博碩士論文加值系統

(3.229.137.68) 您好!臺灣時間:2021/07/25 18:25
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:楊博閔
研究生(外文):Bo-Min Yang
論文名稱:評估CpGisland的甲基化程度與女性肺腺癌中低量表現基因之關聯
論文名稱(外文):To evaluate the correlation between methylation status of CpG island and down-regulation gene in female lung adenocarcinoma
指導教授:賴金美
指導教授(外文):Jin-Mei Lai
學位類別:碩士
校院名稱:輔仁大學
系所名稱:生命科學系碩士班
學門:生命科學學門
學類:生物學類
論文種類:學術論文
論文出版年:2007
畢業學年度:95
語文別:中文
外文關鍵詞:DNA methylationCpG islandbisulfite sequencingfemale lung adenocarcinoma
相關次數:
  • 被引用被引用:0
  • 點閱點閱:210
  • 評分評分:
  • 下載下載:34
  • 收藏至我的研究室書目清單書目收藏:0
肺癌是目前台灣與世界各地癌症患者主要的死亡原因,其中肺腺癌是女性肺癌發生的最主要型態,由於85%的女性肺腺癌屬於非吸煙族群,顯示女性肺腺癌的發生可能歸咎於特殊的基因體。許多副基因體的修飾機制,例如DNA甲基化作用可能抑制抑癌基因的表現而導致癌症發生,因此我們藉由分析基因之甲基化情形,來探討其是否為女性肺腺癌中部分低量表現基因的調控機制。在18位不吸煙的女性肺腺癌患者基因微陣列(microarray)的分析中,我們鎖定八個包括FAM134B、MOSC2、PTPRM、KIAA0256、GPRC5A、CXCL5、EDNRB、PDPN在腫瘤組織中表現量顯著較鄰近正常組織為低的基因。為了要分析與呈現這些基因CpG island的甲基化狀態,我們利用酸性亞硫酸鈉(sodium bisulfite)處理基因體(genomic)DNA,將未甲基化之胞嘧啶(cytosine)轉化成尿嘧啶(uracil),利用nest PCR增幅CpG island片段後進行定序。分別分析一個正常肺細胞株IMR90與14個肺癌細胞株之上述八個基因後,我們發現MOSC2、CXCL5、EDNRB在多個肺癌細胞株呈現高度甲基化而在正常細胞株呈現低度甲基化。此外使用DNA methyltransferase抑制劑5-aza-2'-deoxycytidine處理細胞,可見隨濃度的提高,基因的表現量有逐漸回升的現象,顯示DNA甲基化作用可能確實是MOSC2、CXCL5、EDNRB在肺癌細胞株中表現量降低的調控機制。
Lung cancer is currently the leading cause of cancer death worldwide as well as in Taiwan. Adenocarcinoma is the most prevalent histological type among female lung cancer. It was noticed that 85 percent of female adenocarcinoma patients are nonsmokers, indicating their higher risks may as least, in part, impute to their distinctive genome. As epigenetic mechanism, such as DNA methylation, has been implicated in regulation of tumor suppressor genes, we therefore analyze whether DNA methylation is the mechanism that affect the gene which is down-regulated in female lung adenocarcinoma. By analyzing microarray profiling of tissue pair from 18 lung adenocarcinoma patients, eight genes including FAM134B, MOSC2, PTPRM, CXCL5, KIAA0256, GPRC5A, EDNRB, and PDPN have been found to down regulated in lung cancer tissue as compared with adjacent normal part. In attempt to analyze whether these genes have CpG islands and display hypermethylation pattern, we used sodium bisulfite conversion method to treat genomic DNA and to sequence the putative CpG island of each gene. After analyzed the methylation status of CpG islands of these genes in one normal lung fibroblast, IMR90, and fourteen lung cancer cell lines, we have found MOSC2, CXCL5 and EDNRB displayed hypermethylation in many lung cancer cell lines as compared to IMR90. In addition, DNA methyltransferase inhibitor, 5-aza-2’-deoxycitidine, can revert their down regulation in a dose dependent manner, indicating DNA methylation may indeed the mechanism that down-regulates the expression of MOSC2, CXCL5 and EDNRB in lung cancer cell lines.
中文摘要 1
Abstract 2
壹、序論 3
貳、實驗材料 15
參、實驗方法 18
肆、結果 28
伍、討論 44
陸、圖表 50
柒、附錄 73
捌、參考文獻 94
Arenberg, D.A., M.P. Keane, B. DiGiovine, S.L. Kunkel, S.B. Morris, Y.Y. Xue, M.D. Burdick, M.C. Glass, M.D. Iannettoni, and R.M. Strieter. 1998. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest. 102:465-72.
Balsara, B.R., and J.R. Testa. 2002. Chromosomal imbalances in human lung cancer. Oncogene. 21:6877-83.
Baylin, S.B. 2005. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2 Suppl 1:S4-11.
Bickle, T.A., and D.H. Kruger. 1993. Biology of DNA restriction. Microbiol Rev. 57:434-50.
Brambilla, E., W.D. Travis, T.V. Colby, B. Corrin, and Y. Shimosato. 2001. The new World Health Organization classification of lung tumours. Eur Respir J. 18:1059-68.
Buryanov, Y., and T. Shevchuk. 2005. The use of prokaryotic DNA methyltransferases as experimental and analytical tools in modern biology. Anal Biochem. 338:1-11.
Chen, J.J., K. Peck, T.M. Hong, S.C. Yang, Y.P. Sher, J.Y. Shih, R. Wu, J.L. Cheng, S.R. Roffler, C.W. Wu, and P.C. Yang. 2001. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res. 61:5223-30.
Chen, K.Y., C.H. Chang, C.J. Yu, S.H. Kuo, and P.C. Yang. 2005. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer. 103:2566-74.
Clark, S.J., A. Statham, C. Stirzaker, P.L. Molloy, and M. Frommer. 2006. DNA methylation: bisulphite modification and analysis. Nat Protoc. 1:2353-64.
Dong, A., J.A. Yoder, X. Zhang, L. Zhou, T.H. Bestor, and X. Cheng. 2001. Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acids Res. 29:439-48.
Du, W., and J. Pogoriler. 2006. Retinoblastoma family genes. Oncogene. 25:5190-200.
Fuks, F., P.J. Hurd, D. Wolf, X. Nan, A.P. Bird, and T. Kouzarides. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 278:4035-40.
Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J Mol Biol. 196:261-82.
Gebbink, M.F., G.C. Zondag, R.W. Wubbolts, R.L. Beijersbergen, I. van Etten, and W.H. Moolenaar. 1993. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J Biol Chem. 268:16101-4.
Giacinti, C., and A. Giordano. 2006. RB and cell cycle progression. Oncogene. 25:5220-7.
Hellqvist, M., M. Mahlapuu, L. Samuelsson, S. Enerback, and P. Carlsson. 1996. Differential activation of lung-specific genes by two forkhead proteins, FREAC-1 and FREAC-2. J Biol Chem. 271:4482-90.
Hirano, M., L. Zang, T. Oka, Y. Ito, Y. Shimada, Y. Nishimura, and T. Tanaka. 2006. Novel reciprocal regulation of cAMP signaling and apoptosis by orphan G-protein-coupled receptor GPRC5A gene expression. Biochem Biophys Res Commun. 351:185-91.
Hsu, L.S., H.C. Lee, G.Y. Chau, P.H. Yin, C.W. Chi, and W.Y. Lui. 2006. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep. 15:507-11.
Jang, S.J., and L. Mao. 2000. Methylation patterns in human androgen receptor gene and clonality analysis. Cancer Res. 60:864-6.
Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun. 2007. Cancer statistics, 2007. CA Cancer J Clin. 57:43-66.
Ju, Z., M. Kapoor, K. Newton, K. Cheon, A. Ramaswamy, R. Lotan, L.C. Strong, and J.S. Koo. 2005. Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells. Mol Genet Genomics. 274:141-54.
Kawasaki, H., and K. Taira. 2004. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature. 431:211-7.
Keates, A.C., S. Keates, J.H. Kwon, K.O. Arseneau, D.J. Law, L. Bai, J.L. Merchant, T.C. Wang, and C.P. Kelly. 2001. ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells. J Biol Chem. 276:43713-22.
Kikuno, R., T. Nagase, M. Waki, and O. Ohara. 2002. HUGE: a database for human large proteins identified in the Kazusa cDNA sequencing project. Nucleic Acids Res. 30:166-8.
Kim, K.H., J.S. Choi, I.J. Kim, J.L. Ku, and J.G. Park. 2006. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. World J Gastroenterol. 12:5651-7.
Klose, R.J., and A.P. Bird. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 31:89-97.
Lahav, R., M.L. Suva, D. Rimoldi, P.H. Patterson, and I. Stamenkovic. 2004. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res. 64:8945-53.
Lewin, J., A. Plum, T. Hildmann, T. Rujan, F. Eckhardt, V. Liebenberg, C. Lofton-Day, and R. Wasserkort. 2007. Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisation. Int J Biochem Cell Biol. 39:1539-50.
Lian, J., X. Dai, X. Li, and F. He. 2006. Identification of an active site on the laminin alpha4 chain globular domain that binds to alphavbeta3 integrin and promotes angiogenesis. Biochem Biophys Res Commun. 347:248-53.
Lu, Y., W. Lemon, P.Y. Liu, Y. Yi, C. Morrison, P. Yang, Z. Sun, J. Szoke, W.L. Gerald, M. Watson, R. Govindan, and M. You. 2006. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med. 3:e467.
Melki, J.R., P.C. Vincent, R.D. Brown, and S.J. Clark. 2000. Hypermethylation of E-cadherin in leukemia. Blood. 95:3208-13.
Miyazaki, H., V. Patel, H. Wang, R.K. Edmunds, J.S. Gutkind, and W.A. Yeudall. 2006. Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res. 66:4279-84.
Murrell, A., V.K. Rakyan, and S. Beck. 2005. From genome to epigenome. Hum Mol Genet. 14 Spec No 1:R3-R10.
Oda, K., Y. Matsuoka, A. Funahashi, and H. Kitano. 2005. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 1:2005 0010.
Ohara, O., T. Nagase, K. Ishikawa, D. Nakajima, M. Ohira, N. Seki, and N. Nomura. 1997. Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins. DNA Res. 4:53-9.
Okano, M., S. Xie, and E. Li. 1998. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 26:2536-40.
Olayioye, M.A., R.M. Neve, H.A. Lane, and N.E. Hynes. 2000. The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J. 19:3159-67.
Oshima, T., C. Wada, Y. Kawagoe, T. Ara, M. Maeda, Y. Masuda, S. Hiraga, and H. Mori. 2002. Genome-wide analysis of deoxyadenosine methyltransferase-mediated control of gene expression in Escherichia coli. Mol Microbiol. 45:673-95.
Panani, A.D., and C. Roussos. 2006. Cytogenetic and molecular aspects of lung cancer. Cancer Lett. 239:1-9.
Parkin, D.M., F. Bray, J. Ferlay, and P. Pisani. 2005. Global cancer statistics, 2002. CA Cancer J Clin. 55:74-108.
Peltomaki, P. 2001. DNA mismatch repair and cancer. Mutat Res. 488:77-85.
Pirozynski, M. 2006. 100 years of lung cancer. Respir Med. 100:2073-84.
Ponder, B.A. 2001. Cancer genetics. Nature. 411:336-41.
Raizis, A.M., F. Schmitt, and J.P. Jost. 1995. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal Biochem. 226:161-6.
Roberts, P.J., and C.J. Der. 2007. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 26:3291-310.
Sanchez-Cespedes, M., S.A. Ahrendt, S. Piantadosi, R. Rosell, M. Monzo, L. Wu, W.H. Westra, S.C. Yang, J. Jen, and D. Sidransky. 2001. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res. 61:1309-13.
Sanz-Ortega, J., F. Roig, M.M. Al-Mousa, M.C. Saez, A. Munoz, J. Sanz-Esponera, and L. Callol. 2007. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer. Histol Histopathol. 22:541-5.
Schaefer, B.C. 1995. Revolutions in rapid amplification of cDNA ends: new strategies for polymerase chain reaction cloning of full-length cDNA ends. Anal Biochem. 227:255-73.
Shames, D.S., L. Girard, B. Gao, M. Sato, C.M. Lewis, N. Shivapurkar, A. Jiang, C.M. Perou, Y.H. Kim, J.R. Pollack, K.M. Fong, C.L. Lam, M. Wong, Y. Shyr, R. Nanda, O.I. Olopade, W. Gerald, D.M. Euhus, J.W. Shay, A.F. Gazdar, and J.D. Minna. 2006. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 3:e486.
Sherr, C.J. 2004. Principles of tumor suppression. Cell. 116:235-46.
Suzuki, Y., T. Tsunoda, J. Sese, H. Taira, J. Mizushima-Sugano, H. Hata, T. Ota, T. Isogai, T. Tanaka, Y. Nakamura, A. Suyama, Y. Sakaki, S. Morishita, K. Okubo, and S. Sugano. 2001. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res. 11:677-84.
Takai, D., Y. Yagi, K. Wakazono, N. Ohishi, Y. Morita, T. Sugimura, and T. Ushijima. 2001. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene. 20:7505-13.
Toyooka, S., R. Maruyama, K.O. Toyooka, D. McLerran, Z. Feng, Y. Fukuyama, A.K. Virmani, S. Zochbauer-Muller, K. Tsukuda, K. Sugio, N. Shimizu, K. Shimizu, H. Lee, C.Y. Chen, K.M. Fong, M. Gilcrease, J.A. Roth, J.D. Minna, and A.F. Gazdar. 2003. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer. 103:153-60.
Turek-Plewa, J., and P.P. Jagodzinski. 2005. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett. 10:631-47.
Vance, K.W., S. Carreira, G. Brosch, and C.R. Goding. 2005. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65:2260-8.
Verdone, L., E. Agricola, M. Caserta, and E. Di Mauro. 2006. Histone acetylation in gene regulation. Brief Funct Genomic Proteomic. 5:209-21.
Wicki, A., and G. Christofori. 2007. The potential role of podoplanin in tumour invasion. Br J Cancer. 96:1-5.
Wilson, G.G. 1991. Organization of restriction-modification systems. Nucleic Acids Res. 19:2539-66.
Wu, K., M. Liu, A. Li, H. Donninger, M. Rao, X. Jiao, M.P. Lisanti, A. Cvekl, M. Birrer, and R.G. Pestell. 2007. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Mol Biol Cell. 18:755-67.
Yanagawa, N., G. Tamura, H. Oizumi, N. Takahashi, Y. Shimazaki, and T. Motoyama. 2003. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci. 94:589-92.
Yates, D.R., I. Rehman, M.F. Abbod, M. Meuth, S.S. Cross, D.A. Linkens, F.C. Hamdy, and J.W. Catto. 2007. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res. 13:2046-53.
Zhang, Z., D. Sun, N. Van do, A. Tang, L. Hu, and G. Huang. 2007. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int J Cancer. 120:32-8.
Zhu, J., and X. Yao. 2007. Use of DNA methylation for cancer detection and molecular classification. J Biochem Mol Biol. 40:135-41.
Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-25.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
1. 王淑娟(2002)。他山之石可以攻錯─各國中途輟學學生現況及中輟生防治政策簡介。學生輔導,81,132-141。
2. 王淑娟、洪麗芬(2002)。我國「國民中小學中途輟學生預防、輔導及復學」政策簡述。學生輔導,82,122-137。
3. 王瓊珠(2001)。普通班教師如何協助學習障礙學生。國小特殊教育,31,55-60。
4. 任宜菁(2003)。花蓮縣特殊教育不分類巡迴輔導班實施現況概述。花蓮師院特教通訊,29,5-8。
5. 何縕琪(2004)。運用社區資源輔導中輟復學生之行動研究。慈濟大學教育研究學刊,1,59-101。
6. 李文昌(2003)。從「中輟生」、「網咖」談輔導實務。學生輔導,86,92-103。
7. 吳芝儀(1998)。中輟學生的另類選擇學校。職教園地雜誌,22,11-15。
8. 吳芝儀(2000a)。國中階段中輟學生輟學經驗與危機因素之研究。犯罪學期刊,5,179-232。
9. 吳秀玉(2006)。淺談中輟學生的成因、需求與因應方案。師說:中華民國全國教育會月刊,190,20-23。
10. 吳昆壽(1998)。融合教育的省思。特教新知通訊,5(7),1-4。
11. 周愫嫻(2000)。社會結構、中途輟學率與少年犯罪率關係之研究。臺北市立師範學院學報,31,243-268。
12. 周愫嫻(2005)。提早離開港灣的小船―論學生中輟的家庭因素及其對策。教師天地,137,4-14。
13. 周愫嫻、張耀中(2005)。臺灣中輟問題的核心議題:現象與趨勢分析。國教新知,52(4),50-64。
14. 洪雅琴(2004)。身心障礙學生的心理輔導—評論「身心障礙生的輔導方式與成效:以一個躁鬱症學生為例」一文。學生輔導,90,121-126。
15. 洪儷瑜(1999)。學校如何因應情緒障礙學生的特殊需求─談情緒障礙特殊教育。特殊教育季刊,71,7-12。